LA CIOTAT, France — November 25, 2025 — Leads & Copy — Avicenna.AI, a medical imaging AI company, has partnered with Ferrum Health to expand U.S. access to its advanced imaging AI solutions through Ferrum’s AI Governance Suite.
Ferrum, an AI Governance Suite that supports more than 50 industry-leading algorithms, will commercialize Avicenna.AI’s complete portfolio of imaging AI solutions across the United States, according to the agreement.
Ferrum’s suite provides clinicians with access to advanced AI technologies that enhance diagnostic accuracy in oncology, women’s and men’s health, cardiovascular care, neurology, and orthopedics. The addition of Avicenna’s emergency and high-impact imaging solutions to Ferrum’s library bolsters Ferrum’s standing as a comprehensive AI marketplace in healthcare.
Avicenna.AI provides a suite of deep learning solutions designed to detect, identify, and quantify life-threatening conditions using CT imaging. Its CINA solutions support radiologists by accelerating the detection of critical findings, prioritizing urgent cases, enhancing workflow efficiency, and improving patient outcomes.
The portfolio includes AI solutions for:
- Intracranial hemorrhage (CINA-ICH)
- Large vessel occlusion (CINA-LVO)
- Aortic dissection (CINA-AD)
- Pulmonary embolism (CINA-PE and CINA-iPE)
- Vertebral compression fractures (CINA-VCF)
- Cervical spine fractures (CINA-CSpine)
- ASPECT scoring for stroke severity (CINA-ASPECTS)
Ferrum’s platform enables clinicians to validate AI performance on local datasets and integrate AI into existing workflows, ensuring that protected health information (PHI) remains within the health system’s firewall.
Pelu Tran, CEO of Ferrum Health, said that radiologists and clinicians are asking for AI that truly moves the needle for patients, and that partnering with Avicenna.AI allows Ferrum to put some of the most trusted emergency imaging tools directly into the hands of the health systems they serve, expanding access to life-saving technology across the U.S.
Cyril Di Grandi, co-founder and CEO of Avicenna.AI, said that their mission is to make high-performance, clinically proven AI accessible to as many clinicians as possible, and that Ferrum’s enterprise-ready platform is the ideal partner to accelerate U.S. adoption and ensure their solutions are deployed safely, efficiently, and at scale.
Avicenna.AI will be present at RSNA 2025, offering demonstrations and presentations alongside multiple partners. To book a meeting with the company, visit: https://meetings-eu1.hubspot.com/martijn-jonkers/rsna-2025-meet-with-avicennaai
Ferrum Health connects AI insights across service lines, turning fragmented deployments into enterprise clinical intelligence. Their vendor-neutral suite validates and monitors clinical AI models within a health system’s owned, secure environment. Organizations use Ferrum to deploy models faster, validate performance objectively, and maintain complete visibility across their AI portfolio. Backed by $31 million in funding, including a Series A led by Foundry, serving over 500 care sites globally.
Founded in 2018, Avicenna.AI specializes in healthcare AI solutions that use deep learning to identify, detect, and quantify severe pathologies from CT medical images. Co-founded by entrepreneur Cyril Di Grandi and Dr. Peter Chang, an internationally recognized radiologist and AI expert, Avicenna.AI aims to accelerate therapeutic decision-making and improve patient outcomes.
Source: Avicenna.AI
